Bharatt Chowrira, Ph.D., J.D., named Chief Executive Officer of PureTech; PureTech Co-founder, Eric Elenko, Ph.D., promoted to President PureTech Founding Chief ...
PureTech Health has spied an opportunity to improve on Jazz Pharmaceuticals’ Epidiolex. Armed with its Glyph chemistry platform, the biotech has created an oral capsule formulation of cannabidiol (CBD ...
Maintained a strong financial position with $319.6M PureTech level cash, cash equivalents and short-term investments and $319.9M Consolidated cash, cash equivalents and short-term investments as of ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc ("PureTech" or the "Company", LSE:PRTC), a cross-disciplinary healthcare company developing novel medicines to tackle fundamental healthcare needs in ...
PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in R/R High-Risk Myelodysplastic Syndrome & R/R Acute Myeloid Leukemia ...
Roche has struck a deal with PureTech Health to develop oral antisense oligonucleotides. The pact gives Roche access to PureTech’s milk-derived exosome technology in return for up to $36 million (€31 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Daphne Zohar, who founded Boston ...
PureTech Health(NASDAQ:PRTC) reported its second quarter 2025 earnings on Aug. 28, 2025, highlighting a cash balance of just under $320 million at the end of the first half of 2025, a reduction in ...
Infobird Co., Ltd, a Nasdaq-listed company, has entered into an agreement to acquire 32% of Pure Tech Global Limited for approximately $25.7 million. The purchase will be paid in cash and a ...
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results